{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:58:00Z","timestamp":1793159880075,"version":"4.5.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research on the Epidemiology of Severe Drug-induced Diseases of the Chinese Society of Toxicology","award":["CST2019CT304"],"award-info":[{"award-number":["CST2019CT304"]}]},{"name":"Key Specialties Foundation of Clinical Pharmacy of Shanghai Municipal Health Commission in China","award":["SWLCYXZX-2018-001"],"award-info":[{"award-number":["SWLCYXZX-2018-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Proton pump inhibitor (PPI) abuse poses an overwhelming threat to the allocation of medical resources and places a heavy burden on global medical expenses. In this study, we put forward our prospective prescription review system and evaluated the effects of this system on clinical outcomes, rational medication use and costs related to PPIs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective cohort study was conducted in which the included patients were divided into a preintervention group (2019.10\u20132020.09) and a postintervention group (2020.10\u20132021.09). To reduce the bias of patients\u2019 baseline characteristics, the propensity score matching (PSM) method was employed. The primary endpoints were the incidence of stress ulcers (SUs), the improvement and cure rates of gastrointestinal haemorrhage, the defined daily dose (DDD), the drug utilization index (DUI) and the DDD\/100 patient-days. The secondary endpoints included the types of unreasonable medication orders for PPIs, the PPI utilization rate and PPI costs.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 53,870 patients were included to evaluate the secondary endpoints, and 46,922 patients were paired by PSM and assessed to evaluate the primary endpoints. The number of PPIs used and PPI costs were significantly lower in the postintervention group than in the preintervention group (P\u2009&lt;\u20090.001). The rationality evaluation results showed that the frequency of PPI use and the number of drug interactions were significantly higher in the preintervention group than in the postintervention group (P\u2009&lt;\u20090.01). The proportion of patients taking oral PPIs was significantly increased in the postintervention group (29.30% vs. 34.56%, p\u2009&lt;\u20090.01). For the utilization of PPIs both for prevention and treatment, the DUI and DDD\/100 patient-days were substantially decreased in the postintervention group (P\u2009&lt;\u20090.001 and P\u2009&lt;\u20090.05, respectively). The incidence of SUs in the postintervention group was 44.95%, and that in the preintervention group was 51.93% (p\u2009&lt;\u20090.05).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The implementation of the prospective prescription review system on rational PPI use correlated with reduced PPI costs, more rational PPI medication use and better clinical outcomes, and this system is worthy of long-term implementation for further improvement of rational drug use.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-09931-5","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T13:02:20Z","timestamp":1695214940000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Prospective prescription review system correlated with more rational PPI medication use, better clinical outcomes and reduced PPI costs: experience from a retrospective cohort study"],"prefix":"10.1186","volume":"23","author":[{"given":"Xiucong","family":"Fan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siwei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaogang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weijun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yabin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobo","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"issue":"2","key":"9931_CR1","first-page":"129","volume":"34","author":"J Wei","year":"2018","unstructured":"Wei J, Chang J, Jiang R, Kang D, Li L, You C, Zhang J, Zhao G, Gao L, Huang Q, Luo D, Zhang H, Wu H, Wang S, Wang R. Risk factors for stress ulcer bleeding in neurocritical patients: a multi-center study. Chin J Neurosurg. 2018;34(2):129\u201333.","journal-title":"Chin J Neurosurg"},{"issue":"7","key":"9931_CR2","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1007\/s00228-014-1681-2","volume":"70","author":"MD Larsen","year":"2014","unstructured":"Larsen MD, Schou M, Kristiansen AS, Hallas J. The influence of hospital drug formulary policies on the prescribing patterns of proton pump inhibitors in primary care. Eur J Clin Pharmacol. 2014;70(7):859\u201365.","journal-title":"Eur J Clin Pharmacol"},{"key":"9931_CR3","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jamda.2013.01.021","volume":"14","author":"D Patterson Burdsall","year":"2013","unstructured":"Patterson Burdsall D, Flores HC, Krueger J, Garretson S, Gorbien MJ, Iacch A, Dobbs V, Homa T. Use of proton pump inhibitors with lack of diagnostic indications in 22 midwestern US skilled nursing facilities. J Am Med Dir Assoc. 2013;14:429\u201332.","journal-title":"J Am Med Dir Assoc"},{"issue":"7634","key":"9931_CR4","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","volume":"336","author":"I Forgacs","year":"2008","unstructured":"Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ. 2008;336(7634):2\u20133.","journal-title":"BMJ"},{"issue":"9","key":"9931_CR5","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/2042098617715381","volume":"8","author":"ML Maes","year":"2017","unstructured":"Maes ML, Fixen DR, Linnebur SA. Adverse effects of proton-pump inhibitor use in older adults: a review of the evidence. Ther Adv Drug Saf. 2017;8(9):273\u201397.","journal-title":"Ther Adv Drug Saf"},{"issue":"8","key":"9931_CR6","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3748\/wjg.v25.i8.888","volume":"25","author":"D Kockerling","year":"2019","unstructured":"Kockerling D, Nathwani R, Forlano R, Manousou P, Mullish BH, Dhar A. Current and future pharmacological therapies for managing cirrhosis and its complications. World J Gastroenterol. 2019;25(8):888\u2013908.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"9931_CR7","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1001\/jamainternmed.2015.7193","volume":"176","author":"B Lazarus","year":"2016","unstructured":"Lazarus B, Chen Y, Wilson FP, Sang Y, Chang AR, Coresh J, Grams ME. Proton Pump inhibitor use and the risk of chronic kidney disease. JAMA Intern Med. 2016;176(2):238\u201346.","journal-title":"JAMA Intern Med"},{"issue":"21","key":"9931_CR8","doi-asserted-by":"publisher","first-page":"2675","DOI":"10.3748\/wjg.v25.i21.2675","volume":"25","author":"YJ Ma","year":"2019","unstructured":"Ma YJ, Cao ZX, Li Y, Feng SY. Proton pump inhibitor use increases hepatic encephalopathy risk: a systematic review and meta-analysis. World J Gastroenterol. 2019;25(21):2675\u201382.","journal-title":"World J Gastroenterol"},{"issue":"12","key":"9931_CR9","first-page":"831","volume":"7","author":"DC Metz","year":"2011","unstructured":"Metz DC. Examining the potential relationship between proton pump inhibitor use and the risk of bone fracture. Gastroenterol Hepatol. 2011;7(12):831\u20133.","journal-title":"Gastroenterol Hepatol"},{"issue":"6","key":"9931_CR10","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1136\/ejhpharm-2018-001697","volume":"27","author":"C Cena","year":"2020","unstructured":"Cena C, Traina S, Parola B, Bo M, Fagiano R, Siviero C. Prescription of proton pump inhibitors in older adults with complex polytherapy. Eur J Hosp Pharm. 2020;27(6):341\u20135.","journal-title":"Eur J Hosp Pharm"},{"issue":"2","key":"9931_CR11","first-page":"114","volume":"16","author":"H Khalili","year":"2010","unstructured":"Khalili H, Dashti-Khavidaki S, Hossein Talasaz AH, Tabeefar H, Hendoiee N. Descriptive analysis of a clinical pharmacy intervention to improve the appropriate use of stress ulcer prophylaxis in a hospital infectious disease ward. J Manag Care Pharm. 2010;16(2):114\u201321.","journal-title":"J Manag Care Pharm"},{"key":"9931_CR12","doi-asserted-by":"crossref","unstructured":"Masood U, Sharma A, Bhatti Z, Carroll J, Bhardwaj A, Sivalingam D, Dhamoon AS. A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit. Inquiry. 2018 Jan-Dec;55:1\u20135.","DOI":"10.1177\/0046958018759116"},{"issue":"8","key":"9931_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.amjmed.2015.02.014","volume":"128","author":"MS Buckley","year":"2015","unstructured":"Buckley MS, Park AS, Anderson CS, Barletta JF, Bikin DS, Gerkin RD, O\u2019Malley CW, Wicks LM, Garcia-Orr R, Kane-Gill SL. Impact of a clinical pharmacist stress Ulcer Prophylaxis Management Program on Inappropriate Use in Hospitalized Patients. Am J Med. 2015;128(8):905\u201313.","journal-title":"Am J Med"},{"issue":"5","key":"9931_CR14","doi-asserted-by":"publisher","first-page":"e0155020","DOI":"10.1371\/journal.pone.0155020","volume":"11","author":"ZK Ye","year":"2016","unstructured":"Ye ZK, Liu Y, Cui XL, Liu LH. Critical appraisal of the quality of clinical practiceguidelines for stress ulcer prophylaxis. PLoS ONE. 2016;11(5):e0155020.","journal-title":"PLoS ONE"},{"key":"9931_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.2147\/PPA.S150388","volume":"12","author":"CW Xin","year":"2017","unstructured":"Xin CW, Dong Z, Lin MM, Li GH. The impact of pharmaceutical interventions on the rational use of proton pump inhibitors in a chinese hospital. Patient Prefer Adherence. 2017;12:21\u20136.","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"9931_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/jcpt.13273","volume":"46","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Yang H, Kong J, Liu L, Ran L, Zhang X, Yun J, Gu Q. Impact of interventions targeting theinappropriate useof proton-pump inhibitors by clinical pharmacists in a hepatobiliary surgery department. J Clin Pharm Ther. 2021;46(1):149\u201357.","journal-title":"J Clin Pharm Ther"},{"issue":"10","key":"9931_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/0300060520954729","volume":"48","author":"Y Hong","year":"2020","unstructured":"Hong Y, Ye ZQ, Gao Z, Rao Y. Continuous improvement onthe rationality of prophylacticinjectable PPIs usage by aclinical pharmacist-led guidance team at a Chinesetertiary teaching hospital. J Int Med Res. 2020;48(10):1\u201315.","journal-title":"J Int Med Res"},{"issue":"2","key":"9931_CR18","first-page":"8","volume":"24","author":"J Bian","year":"2020","unstructured":"Bian J, Wei L, Shao X, Wu K, Zhen J. Investigation and analysis of prescription review and evaluation in chinese hospitals. Chin hosp. 2020;24(2):8\u201311.","journal-title":"Chin hosp"},{"issue":"1","key":"9931_CR19","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12325-021-01935-z","volume":"39","author":"H Xie","year":"2022","unstructured":"Xie H, Zhang H, Peng J, Li L, Geng Y, Ge W. Prospective prescription review system promotes safe use of Analgesics, improves clinical outcomes, and saves medical costs in Surgical Patients: insights from Nanjing Drum Tower Hospital. Adv Therapy. 2022;39(1):441\u201354.","journal-title":"Adv Therapy"},{"key":"9931_CR20","unstructured":"Bo Y, Li YQ, Ren X, Li ZS. Expert Recommendations on Stress Ulcer Prevention and Treatment (2018).Natl Med J China.2018;98(42):3392-5."},{"issue":"2","key":"9931_CR21","first-page":"139","volume":"15","author":"JP Quenot","year":"2009","unstructured":"Quenot JP, Thiery N, Barbar S. When should stress ulcer prophylaxis be used in the ICU? CurrOpin Crit Care. 2009;15(2):139\u201343.","journal-title":"CurrOpin Crit Care"},{"issue":"5","key":"9931_CR22","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373\u201383.","journal-title":"J Chronic Dis"},{"issue":"5","key":"9931_CR23","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/jppr.1548","volume":"49","author":"HY Meng","year":"2019","unstructured":"Meng HY, Yip G, Edwards A, D\u2019Intini V, Tong E. Appropriateness of proton pump inhibitor use in patients admitted under the general medical unit. J Pharm Pract Res. 2019;49(5):447\u201353.","journal-title":"J Pharm Pract Res"},{"key":"9931_CR24","doi-asserted-by":"crossref","unstructured":"ChelseaLT, Cindy B, Sherilyn JY, Bekeart L, Anglemyer A, Tsourounis C, Rennke S. An Interprofessional Approach to reducing the overutilization of stress Ulcer Prophylaxis in Adult Medical and Surgical Intensive Care Units. Annals of Pharmacotherapy.2014;48(4).","DOI":"10.1177\/1060028013517088"},{"issue":"1","key":"9931_CR25","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1186\/s12913-018-3306-4","volume":"18","author":"Z Bao","year":"2018","unstructured":"Bao Z, Ji C, Jing H, Luo C, Fang W. Clinical and economic impact of pharmacist interventions on sampled outpatient prescriptions in a chinese teaching hospital. BMC Health Serv Res. 2018;18(1):519.","journal-title":"BMC Health Serv Res"},{"issue":"8","key":"9931_CR26","doi-asserted-by":"publisher","first-page":"e1507","DOI":"10.1097\/PTS.0000000000000539","volume":"17","author":"P Renaudin","year":"2021","unstructured":"Renaudin P, Coste A, Audurier Y, Berbis J, Canovas F, Jalabert A, Castet-Nicolas A, Mercier G, Villiet M, Dagneaux L, Breuker C. Clinical, economic, and Organizational Impact of the clinical pharmacist in an orthopedic and trauma surgery Department. J Patient Saf. 2021;17(8):e1507\u201313.","journal-title":"J Patient Saf"},{"issue":"4","key":"9931_CR27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.2174\/157488410793352067","volume":"5","author":"E Ramirez","year":"2010","unstructured":"Ramirez E, Lei SH, Borobia AM, Pi\u00f1ana E, Fudio S, Mu\u00f1oz R, Campos A, Carcas AJ, Frias J. Overuse of PPIs in patients at admission, during treatment, and at discharge in atertiary spanish hospital. Curr Clin Pharmacol. 2010;5(4):288\u201397.","journal-title":"Curr Clin Pharmacol"},{"key":"9931_CR28","doi-asserted-by":"crossref","unstructured":"Fan X, Chen D, Bao S, Bai R, Fang F, Dong X, Zhang Y, Zhang X, Ma Y, Zhai X. Integrating Multidisciplinary Individualized Medication Recommendations into the Traditional Pharmacists\u2019 Consultation Method: A Retrospective Study Using Propensity Score Matching Analysis. Inquiry. 2022 Jan-Dec;59:469580221081437.","DOI":"10.1177\/00469580221081437"},{"key":"9931_CR29","doi-asserted-by":"publisher","first-page":"864081","DOI":"10.3389\/fphar.2022.864081","volume":"13","author":"Q Chen","year":"2022","unstructured":"Chen Q, Wang Q, Zhang Y. Clinical intervention increases rational use of Proton Pump inhibitors in the general surgery Department. Front Pharmacol. 2022;13:864081.","journal-title":"Front Pharmacol"},{"issue":"02","key":"9931_CR30","first-page":"36","volume":"14","author":"Y Wang","year":"2021","unstructured":"Wang Y, Xu W, Lu N, Zhang S, Shang B, Liu C, et al. Analysis of the effect of \u201c4 + 7\u201dcentralized procurement policy implementation: based on the drug sales data of 9 pilot regions. Chin J Health Policy. 2021;14(02):36\u201343.","journal-title":"Chin J Health Policy"},{"key":"9931_CR31","unstructured":"He J, Tang M, Cong L, Xu Y, Song J, Chen M et al. The impact of National Centralized drug procurement on the clinical management and drug use. Chin Health Resour. 2021:1\u20133."},{"issue":"8","key":"9931_CR32","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3748\/wjg.v16.i8.982","volume":"16","author":"SC Nasser","year":"2010","unstructured":"Nasser SC, Nassif JG, Dimassi HI. Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients. World J Gastroenterol. 2010;16(8):982\u20136.","journal-title":"World J Gastroenterol"},{"issue":"20","key":"9931_CR33","first-page":"1775","volume":"12","author":"Writing Group of Expert Consensus on the Preventive Application of Proton Pump Inhibitors","year":"2018","unstructured":"Writing Group of Expert Consensus on the Preventive Application of Proton Pump Inhibitors. Expert consensus on the preventive application of proton pump inhibitors. J Chin Phys. 2018;12(20):1775\u201381.","journal-title":"J Chin Phys"},{"issue":"1","key":"9931_CR34","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1186\/s12916-016-0718-z","volume":"14","author":"C Scarpignato","year":"2016","unstructured":"Scarpignato C, Gatta L, Zullo A, Blandizzi C, SIF-AIGO-FIMMG Group. Italian society of Pharmacology, the Italian Association of Hospital Gastroenterologists, and the Italian Federation of General Practitioners. Effective and safe proton pump inhibitor therapy in acid -related diseases -A position paper addressing benefits and potential harms of acid suppression. BMC Med. 2016;14(1):179.","journal-title":"BMC Med"},{"issue":"7","key":"9931_CR35","first-page":"728","volume":"35","author":"YP Zhao","year":"2015","unstructured":"Zhao YP. Prevention and treatment of stress related mucosal disease: consensus of experts in general surgery in China (2015). Chin J Pract Surg. 2015;35(7):728\u201330.","journal-title":"Chin J Pract Surg"},{"issue":"2","key":"9931_CR36","first-page":"184","volume":"38","author":"XF Mao","year":"2020","unstructured":"Mao XF, Yang ZW. Medical big data analysis of the clinical off-label use of proton pump inhibitors. The J Pharm Pract. 2020;38(2):184\u20138.","journal-title":"The J Pharm Pract"},{"key":"9931_CR37","doi-asserted-by":"publisher","first-page":"e0170495","DOI":"10.1371\/journal.pone.0170495","volume":"12","author":"CM Hohl","year":"2017","unstructured":"Hohl CM, Partovi N, Ghement I, Wickham ME, McGrail K, Reddekopp LN, Sobolev B. Impact of early in-hospital medication review by clinical pharmacists on health services utilization. PLoS ONE. 2017;12:e0170495.","journal-title":"PLoS ONE"},{"issue":"10","key":"9931_CR38","first-page":"738","volume":"111","author":"J Ying","year":"2019","unstructured":"Ying J, Li LC, Wu CY, Yu ZW, Kan LD. The status of proton pump inhibitor use: a prescription survey of 45 hospitals in China. Rev EspEnferm Dig. 2019;111(10):738\u201343.","journal-title":"Rev EspEnferm Dig"},{"key":"9931_CR39","first-page":"5066","volume":"36","author":"TX Wu","year":"2016","unstructured":"Wu TX, Wang B, Wang YD. Evaluation of clinical pharmaceutical care by doctors in five \u201ctop three. Hosp Beijing Chin Pharm J. 2016;36:5066\u20138.","journal-title":"Hosp Beijing Chin Pharm J"},{"issue":"6","key":"9931_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11096-016-0395-1","volume":"38","author":"C B\u00b4echet","year":"2016","unstructured":"B\u00b4echet C, Pichon R, Giordan A, Bonnabry P. Hospital pharmacistsseen through the eyes of physicians: qualitative semi-structured interviews. Int J Clin Pharm. 2016;38(6):1\u201314.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"9931_CR41","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1186\/s12889-021-11882-7","volume":"21","author":"N Wang","year":"2021","unstructured":"Wang N, Yang Y, Xu LX, Mao ZF, Cui D. Influence of Chinese National Centralized drug procurement on the price of policy-related drugs: an interrupted time series analysis. BMC Public Health. 2021;21(1):1883.","journal-title":"BMC Public Health"},{"key":"9931_CR42","doi-asserted-by":"publisher","first-page":"944540","DOI":"10.3389\/fphar.2022.944540","volume":"13","author":"H Long","year":"2022","unstructured":"Long H, Yang Y, Geng X, Mao Z, Mao Z. Changing characteristics of Pharmaceutical prices in China under centralized procurement policy: a Multi-Intervention interrupted Time Series. Front Pharmacol. 2022;13:944540.","journal-title":"Front Pharmacol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09931-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-09931-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-09931-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T10:25:20Z","timestamp":1700389520000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-09931-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["9931"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-09931-5","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"23 January 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were conducted following relevant guidelines and regulations. This study was approved by the Research Ethics Committee of Tongji University affiliated East Hospital Review Board (2020-092). The need for written informed consent was waived by the Research Ethics Committee of Tongji University affiliated East Hospital due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The author(s) declared no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1014"}}